[Effect of BRL 25000 (clavulanic acid-amoxicillin) on bacterial flora in human feces]. 1985

T Motohiro, and K Tanaka, and T Koga, and Y Shimada, and N Tomita, and Y Sakata, and T Fujimoto, and T Nishiyama, and N Kuda, and K Ishimoto

BRL 25000 (187.5 and 375 mg tablets), a formulation of CVA-K and AMPC in the ratio of 1:2, and AMPC (as control drug) were administered to healthy volunteers, aged 20 approximately 28 years and weighing 60 approximately 85 kg (68.8 kg, on average). Each drug was administered 3 times a day (after meals) for 5 days and the volunteers were separated into 3 groups of 4 subjects each. The effect on the fecal flora was studied before dosage, during administration (day 3 and 5) and day 3 and 5 after the administration course was completed. Studies were undertaken to isolate C. difficile on the last day of administration and 3 and 5 days after administration had ceased. Fecal concentrations and the susceptibility of the isolates to AMPC, CVA-K and BRL 25000 were measured. Side effects and laboratory findings were studied. The results obtained were as follows: 1. In BRL 25000 (187.5 mg X 3/day) group, the population of E. coli was on average, 1 X 10(6) approximately 9 X 10(6) cells/g feces before initiation of administration and it increased by 2 logarithms 3 and 5 days after initiation of administration. By 3 and 5 days after end of administration, the E. coli population was similar to the initial population. The population of Klebsiella sp. was 1 X 10(6) approximately 9 X 10(6) cells/g feces on average before commencement of dosage and it increased by 2 logarithms 3 days after initiation of administration but there was no consistent change in the Klebsiella sp. population thereafter. The Enterobacter sp., population was not consistent neither was the population of other Enterobacteriaceae. In total, the mean Enterobacteriaceae population was 1 X 10(7) approximately 9 X 10(7) cells/g feces before initiation of administration and increased by 2 logarithms 3 days after initiation of administration, and then returned to the initial level 5 days after end of administration. No consistent changes in population were noted for the other Gram-negative bacilli. The Staphylococcus sp. population was 1 X 10(6) approximately 9 X 10(6) cells/g feces on average before initiation of administration. This organism was detected in only 1 case 3 days after initiation of administration and in another 5 days after initiation of administration, thereafter, the population was similar to the initial population.(ABSTRACT TRUNCATED AT 400 WORDS)

UI MeSH Term Description Entries
D008297 Male Males
D010403 Penicillin Resistance Nonsusceptibility of an organism to the action of penicillins. Penicillin Resistances,Resistance, Penicillin,Resistances, Penicillin
D002969 Clavulanic Acids Acids, salts, and derivatives of clavulanic acid (C8H9O5N). They consist of those beta-lactam compounds that differ from penicillin in having the sulfur of the thiazolidine ring replaced by an oxygen. They have limited antibacterial action, but block bacterial beta-lactamase irreversibly, so that similar antibiotics are not broken down by the bacterial enzymes and therefore can exert their antibacterial effects. Acids, Clavulanic
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004755 Enterobacteriaceae A family of gram-negative, facultatively anaerobic, rod-shaped bacteria that do not form endospores. Its organisms are distributed worldwide with some being saprophytes and others being plant and animal parasites. Many species are of considerable economic importance due to their pathogenic effects on agriculture and livestock. Coliform Bacilli,Enterobacteria,Ewingella,Leclercia,Paracolobactrum,Sodalis
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D006094 Gram-Positive Bacteria Bacteria which retain the crystal violet stain when treated by Gram's method. Gram Positive Bacteria
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

T Motohiro, and K Tanaka, and T Koga, and Y Shimada, and N Tomita, and Y Sakata, and T Fujimoto, and T Nishiyama, and N Kuda, and K Ishimoto
August 1985, The Japanese journal of antibiotics,
T Motohiro, and K Tanaka, and T Koga, and Y Shimada, and N Tomita, and Y Sakata, and T Fujimoto, and T Nishiyama, and N Kuda, and K Ishimoto
February 1985, The Japanese journal of antibiotics,
T Motohiro, and K Tanaka, and T Koga, and Y Shimada, and N Tomita, and Y Sakata, and T Fujimoto, and T Nishiyama, and N Kuda, and K Ishimoto
February 1985, The Japanese journal of antibiotics,
T Motohiro, and K Tanaka, and T Koga, and Y Shimada, and N Tomita, and Y Sakata, and T Fujimoto, and T Nishiyama, and N Kuda, and K Ishimoto
February 1985, The Japanese journal of antibiotics,
T Motohiro, and K Tanaka, and T Koga, and Y Shimada, and N Tomita, and Y Sakata, and T Fujimoto, and T Nishiyama, and N Kuda, and K Ishimoto
February 1985, The Japanese journal of antibiotics,
T Motohiro, and K Tanaka, and T Koga, and Y Shimada, and N Tomita, and Y Sakata, and T Fujimoto, and T Nishiyama, and N Kuda, and K Ishimoto
March 1983, The Japanese journal of antibiotics,
T Motohiro, and K Tanaka, and T Koga, and Y Shimada, and N Tomita, and Y Sakata, and T Fujimoto, and T Nishiyama, and N Kuda, and K Ishimoto
February 1985, The Japanese journal of antibiotics,
T Motohiro, and K Tanaka, and T Koga, and Y Shimada, and N Tomita, and Y Sakata, and T Fujimoto, and T Nishiyama, and N Kuda, and K Ishimoto
February 1985, The Japanese journal of antibiotics,
T Motohiro, and K Tanaka, and T Koga, and Y Shimada, and N Tomita, and Y Sakata, and T Fujimoto, and T Nishiyama, and N Kuda, and K Ishimoto
February 1985, The Japanese journal of antibiotics,
T Motohiro, and K Tanaka, and T Koga, and Y Shimada, and N Tomita, and Y Sakata, and T Fujimoto, and T Nishiyama, and N Kuda, and K Ishimoto
February 1985, The Japanese journal of antibiotics,
Copied contents to your clipboard!